Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 19

1.

Oxidized phospholipids trigger atherogenic inflammation in murine arteries.

Furnkranz A, Schober A, Bochkov VN, Bashtrykov P, Kronke G, Kadl A, Binder BR, Weber C, Leitinger N.

Arterioscler Thromb Vasc Biol. 2005 Mar;25(3):633-8. Epub 2004 Dec 9.

2.

Oxidized phospholipids as modulators of inflammation in atherosclerosis.

Leitinger N.

Curr Opin Lipidol. 2003 Oct;14(5):421-30. Review.

PMID:
14501580
3.

Chemokines in the pathogenesis of vascular disease.

Charo IF, Taubman MB.

Circ Res. 2004 Oct 29;95(9):858-66. Review.

4.

Arrest chemokines.

Ley K.

Microcirculation. 2003 Jun;10(3-4):289-95. Review.

PMID:
12851646
5.

Modulation of atherogenesis by chemokines.

Boisvert WA.

Trends Cardiovasc Med. 2004 May;14(4):161-5. Review.

PMID:
15177267
6.

[Inflammation and atherosclerosis].

Tedgui A, Mallat Z.

Nephrologie. 2003;24(7):411-4. Review. French.

PMID:
14650755
7.

Regulation of inflammatory responses by oxidized phospholipids: structure-function relationships.

Furnkranz A, Leitinger N.

Curr Pharm Des. 2004;10(8):915-21. Review.

PMID:
15032694
8.

Oxidized lipids as mediators of coronary heart disease.

Navab M, Hama SY, Reddy ST, Ng CJ, Van Lenten BJ, Laks H, Fogelman AM.

Curr Opin Lipidol. 2002 Aug;13(4):363-72. Review. Erratum in: Curr Opin Lipidol. 2002 Oct;13(5):589. Ready Srinu T [corrected to Reddy Srinu T].

PMID:
12151851
9.

Physiological effects of oxidized phospholipids and their cellular signaling mechanisms in inflammation.

Greig FH, Kennedy S, Spickett CM.

Free Radic Biol Med. 2012 Jan 15;52(2):266-80. doi: 10.1016/j.freeradbiomed.2011.10.481. Epub 2011 Oct 31. Review.

PMID:
22080084
10.

Apoptotic cells as sources for biologically active oxidized phospholipids.

Kadl A, Bochkov VN, Huber J, Leitinger N.

Antioxid Redox Signal. 2004 Apr;6(2):311-20. Review.

PMID:
15025932
11.

Oxidized phospholipids and isoprostanes in atherosclerosis.

Witztum JL, Berliner JA.

Curr Opin Lipidol. 1998 Oct;9(5):441-8. Review.

PMID:
9812198
12.

Evidence for a role of phospholipid oxidation products in atherogenesis.

Berliner JA, Subbanagounder G, Leitinger N, Watson AD, Vora D.

Trends Cardiovasc Med. 2001 Apr-May;11(3-4):142-7. Review.

PMID:
11686004
13.

Oxidized PLs and vascular inflammation.

Aldrovandi M, O'Donnell VB.

Curr Atheroscler Rep. 2013 May;15(5):323. doi: 10.1007/s11883-013-0323-y. Review.

14.

Oxidized phospholipids: biomarker for cardiovascular diseases.

Ashraf MZ, Kar NS, Podrez EA.

Int J Biochem Cell Biol. 2009 Jun;41(6):1241-4. doi: 10.1016/j.biocel.2008.11.002. Epub 2008 Nov 17. Review.

15.

[Atherogenesis as an immunoinflammatory process].

Nagornev VA, Voskan'iants AN.

Vestn Ross Akad Med Nauk. 2004;(7):3-11. Review. Russian.

PMID:
15293791
16.

Oxidized phospholipids: emerging lipid mediators in pathophysiology.

Deigner HP, Hermetter A.

Curr Opin Lipidol. 2008 Jun;19(3):289-94. doi: 10.1097/MOL.0b013e3282fe1d0e. Review.

PMID:
18460921
17.

Oxidized phospholipid signaling in immune cells.

Thomas CP, O'Donnell VB.

Curr Opin Pharmacol. 2012 Aug;12(4):471-7. doi: 10.1016/j.coph.2012.02.013. Epub 2012 Mar 23. Review.

PMID:
22445283
18.

Accumulating evidence for a role of oxidized phospholipids in infectious diseases.

Matt U, Sharif O, Martins R, Knapp S.

Cell Mol Life Sci. 2015 Mar;72(6):1059-71. doi: 10.1007/s00018-014-1780-3. Epub 2014 Nov 20. Review.

PMID:
25410378
19.

Oxidized phospholipids: from molecular properties to disease.

Fruhwirth GO, Loidl A, Hermetter A.

Biochim Biophys Acta. 2007 Jul;1772(7):718-36. Epub 2007 May 6. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk